1303 related articles for article (PubMed ID: 30362822)
1. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
2. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload.
Wang J; Deng B; Liu Q; Huang Y; Chen W; Li J; Zhou Z; Zhang L; Liang B; He J; Chen Z; Yan C; Yang Z; Xian S; Wang L
Cell Death Dis; 2020 Jul; 11(7):574. PubMed ID: 32710001
[TBL] [Abstract][Full Text] [Related]
3. Mixed lineage kinase 3 requires a functional CRIB domain for regulation of blood pressure, cardiac hypertrophy, and left ventricular function.
Liu PW; Martin GL; Lin W; Huang W; Pande S; Aronovitz MJ; Davis RJ; Blanton RM
Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H513-H522. PubMed ID: 35867711
[TBL] [Abstract][Full Text] [Related]
4. MLK3 mediates impact of PKG1α on cardiac function and controls blood pressure through separate mechanisms.
Calamaras TD; Pande S; Baumgartner RA; Kim SK; McCarthy JC; Martin GL; Tam K; McLaughlin AL; Wang GR; Aronovitz MJ; Lin W; Aguirre JI; Baca P; Liu P; Richards DA; Davis RJ; Karas RH; Jaffe IZ; Blanton RM
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34324442
[TBL] [Abstract][Full Text] [Related]
5. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
[TBL] [Abstract][Full Text] [Related]
6. Xinyang Tablet inhibits MLK3-mediated pyroptosis to attenuate inflammation and cardiac dysfunction in pressure overload.
Wang J; Deng B; Liu J; Liu Q; Guo Y; Yang Z; Fang C; Lu L; Chen Z; Xian S; Wang L; Huang Y
J Ethnopharmacol; 2021 Jun; 274():114078. PubMed ID: 33798659
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide riboside kinase-2 inhibits JNK pathway and limits dilated cardiomyopathy in mice with chronic pressure overload.
Shahzadi SK; Marzook H; Qaisar R; Ahmad F
Clin Sci (Lond); 2022 Jan; 136(2):181-196. PubMed ID: 35048952
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
9. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
10. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
[TBL] [Abstract][Full Text] [Related]
11. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
13. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
[TBL] [Abstract][Full Text] [Related]
14. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
Guo S; Liu Y; Gao L; Xiao F; Shen J; Xing S; Yang F; Zhang W; Shi Q; Li Y; Zhao L
Int J Biol Sci; 2020; 16(8):1335-1348. PubMed ID: 32210723
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
[TBL] [Abstract][Full Text] [Related]
16. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
17. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
18. C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.
Appari M; Breitbart A; Brandes F; Szaroszyk M; Froese N; Korf-Klingebiel M; Mohammadi MM; Grund A; Scharf GM; Wang H; Zwadlo C; Fraccarollo D; Schrameck U; Nemer M; Wong GW; Katus HA; Wollert KC; Müller OJ; Bauersachs J; Heineke J
Circ Res; 2017 Jan; 120(1):66-77. PubMed ID: 27821723
[TBL] [Abstract][Full Text] [Related]
19. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
[TBL] [Abstract][Full Text] [Related]
20. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
